Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000712624 | SCV000843141 | benign | not provided | 2017-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712624 | SCV001982924 | uncertain significance | not provided | 2024-04-05 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004768605 | SCV005381556 | likely benign | not specified | 2024-08-28 | criteria provided, single submitter | clinical testing | Variant summary: PKD1 c.4654G>A (p.Val1552Ile) results in a conservative amino acid change located in the PKD domain (IPR000601) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00022 in 248018 control chromosomes, predominantly at a frequency of 0.0025 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 5 fold of the estimated maximal expected allele frequency for a pathogenic variant in PKD1 causing Polycystic Kidney Disease 1 phenotype (0.0005). To our knowledge, no occurrence of c.4654G>A in individuals affected with Polycystic Kidney Disease 1 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 586277). Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV003928181 | SCV004740970 | likely benign | PKD1-related disorder | 2020-12-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |